Compare SSD & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSD | ICLR |
|---|---|---|
| Founded | 1956 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 9.3B |
| IPO Year | 1996 | 2001 |
| Metric | SSD | ICLR |
|---|---|---|
| Price | $186.91 | $171.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $214.75 | $178.62 |
| AVG Volume (30 Days) | 330.8K | ★ 908.6K |
| Earning Date | 04-27-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | ★ 8.42 | N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $2,332,808,000.00 | N/A |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $5.57 | N/A |
| P/E Ratio | $87.70 | ★ $12.91 |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $156.32 | $66.57 |
| 52 Week High | $213.49 | $203.91 |
| Indicator | SSD | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 39.23 | 69.42 |
| Support Level | $182.86 | $172.65 |
| Resistance Level | $188.51 | $181.82 |
| Average True Range (ATR) | 4.42 | 5.04 |
| MACD | -1.30 | -0.87 |
| Stochastic Oscillator | 2.74 | 97.19 |
Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.